Company
Vor Biopharma
Reinventing the treatment of autoimmune disease by tackling it at its root.
- Business model
- B2B
- Legal name
- Vor Biopharma, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
We are advancing therapies that aim to correct autoimmune disease biology, moving beyond symptom control toward lasting improvement.
Funding snapshot
- Total raised
- $110MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $110M2020-06-30
Funding rounds
- Round, 2020
- $110M2020-06-30, SEC form D sold, 33 investors
Products
- Web
- Telitacicept
Loading relationship preview